Arecor Therapeutics PLC
LSE:AREC
Income Statement
Earnings Waterfall
Arecor Therapeutics PLC
Revenue
|
3.4m
GBP
|
Operating Expenses
|
-13.7m
GBP
|
Operating Income
|
-10.4m
GBP
|
Other Expenses
|
936k
GBP
|
Net Income
|
-9.4m
GBP
|
Income Statement
Arecor Therapeutics PLC
Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | ||
---|---|---|---|---|---|
Revenue | |||||
Revenue |
1
N/A
|
1
+20%
|
2
+73%
|
3
+41%
|
|
Operating Income | |||||
Operating Expenses |
(7)
|
(10)
|
(13)
|
(14)
|
|
Selling, General & Administrative |
(2)
|
(3)
|
(5)
|
(8)
|
|
Research & Development |
(5)
|
(8)
|
(9)
|
(7)
|
|
Depreciation & Amortization |
(0)
|
0
|
(0)
|
0
|
|
Other Operating Expenses |
1
|
1
|
1
|
1
|
|
Operating Income |
(6)
N/A
|
(9)
-46%
|
(10)
-20%
|
(10)
+1%
|
|
Pre-Tax Income | |||||
Interest Income Expense |
(1)
|
(0)
|
0
|
0
|
|
Non-Reccuring Items |
(0)
|
0
|
(0)
|
0
|
|
Total Other Income |
0
|
0
|
0
|
0
|
|
Pre-Tax Income |
(7)
N/A
|
(9)
-26%
|
(11)
-21%
|
(10)
+4%
|
|
Net Income | |||||
Tax Provision |
1
|
1
|
1
|
1
|
|
Income from Continuing Operations |
(6)
|
(7)
|
(9)
|
(9)
|
|
Net Income (Common) |
(6)
N/A
|
(7)
-20%
|
(9)
-25%
|
(9)
-2%
|
|
EPS (Diluted) |
-0.27
N/A
|
-0.26
+4%
|
-0.32
-23%
|
-0.31
+3%
|